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HUMAN LUNG CANCER RISKS FROM RADON – PART II –
INFLUENCE FROM COMBINED ADAPTIVE RESPONSE AND BYSTANDER
EFFECTS – A MICRODOSE ANALYSIS
Bobby E. Leonard  International Academy of Hi-Tech Services, Inc.
Richard E. Thompson  Department of Biostatistics,  Bloomberg School of
Public Health, Johns Hopkins Medical Center
Georgia C. Beecher  International Academy of Hi-Tech Services, Inc.
 In the prior Part I, the potential influence of the low level alpha radiation induced
bystander effect (BE) on human lung cancer risks was examined. Recent analysis of adap-
tive response (AR) research results with a Microdose Model has shown that single low LET
radiation induced charged particles traversals through the cell nucleus activates AR. We
have here conducted an analysis based on what is presently known about adaptive
response and the bystander effect (BE) and what new research is needed that can assist in
the further evaluation human cancer risks from radon. We find that, at the UNSCEAR
(2000) worldwide average human exposures from natural background and man-made
radiations, the human lung receives about a 25% adaptive response protection against the
radon alpha bystander damage. At the UNSCEAR (2000) minimum range of background
exposure levels, the lung receives minimal AR protection but at higher background levels,
in the high UNSCEAR (2000) range, the lung receives essentially 100% protection from
both the radon alpha damage and also the endogenic, spontaneously occurring, poten-
tially carcinogenic, lung cellular damage.
1. INTRODUCTION
We present here Part II of a three part study of the potential effects
of adaptive response radio-protection and bystander effects on the
human health risks from radon. In Part I (Leonard et al. 2009a), we have
primarily examined experimental in vitro data that show the effect of
radon progeny and other high LET alpha particles on the induction of
transformation frequencies and chromosome aberrations in a number of
cell species thus illustrating the potential for alpha particle induction of
carcinogens in human lung tissue. It is found that the cellular dose
response from alpha particles is relatively independent of cell species and
LET of the alpha radiation to within about ± 10% and is non-linear. Thus
a representative alpha particle dose response shape is obtained which
should be applicable to the alpha particle dose response in human lung
tissue. This representative alpha particle dose response is shown in Figure 10
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of Part I (Leonard et al. 2009b). It is then normalized to the Figure 3-2,
of BEIR VI (1999), estimated lung cancer Relative Risk at 400 Bq m-3,
believed to be reliable for both the case-control and underground miners
lung risk data. The normalized dose response is presented as Figure 16 of
Part I (Leonard et al. 2009a). In the Part I analysis, it is found that the
Brenner et al. (2001) BaD microdose Bystander Model is an excellent tool
for the analysis of bystander effects in tissue with however the necessity to
require two alpha particle hits to initiate the Direct Damage component
of the dose response, consistent with observations of Miller et al. (1999).
It is also found that the human lung cancer relative risk should not be
Linear No-Threshold and that underground miners risk data may not be
valid for estimating risks at domestic and workplace radon levels.
This is compatible with premises by others (Little and Wakeford 2001,
Little 2004, Brenner and Sachs 2002, Brenner et at 2001) that Bystander
Effect Damage occurs in human lung tissue from the high LET radon
alpha radiations. We here further premise in this Part II text, also based
on in vitro data, that adaptive response radio-protection most probably is
activated in human lung cells. This predominantly by low LET radiations
received on a continually basis by humans from natural background and
man-made radiations.
2. MATERIALS AND METHODS
2.1 Distinction Between Adaptive Response and the Bystander Effect
The Bystander Effect is the induction of biological effects in cells that
are not directly traversed by a charged particle, but are in the close prox-
imity to cells that are. Investigations have encompassed both deleterious
and beneficial results in un-hit cells as Bystander Effects (Little and
Wakeford 2001, Belyakov et al. 2005, Iyer and Lehnert 2002, Leonard and
Leonard 2008).
Adaptive response, to many, is thought to mean the reduction in the
biological effects of large doses of ionizing radiation by the prior expo-
sure to low doses of radiation. The prior low dose is usually called the
“primer” dose and the subsequent large dose the “challenge” dose. It is
consistently observed that AR is primarily observed from low LET radia-
tions. Recent work has shown the priming dose can also result in a reduc-
tion of endogenic spontaneous, naturally occurring, potentially carcino-
genic cellular damage. Azzam et al. (1996), Redpath et al. (2001) and oth-
ers have logically considered the spontaneous damage priming dose pro-
tection also as Adaptive Response. The AR protection seen in endogenic
spontaneously occurring damage of course has far greater human radia-
tion risks implications since this could affect a reduction in lung cancer
risks worldwide by low LET natural background and man-made radia-
tions. We can say that, for Adaptive Response, the affected cell must be
Radon Lung Cancer, Bystander, Adaptive Response
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traversed and for the Bystander Effect the affected cell is not traversed.
The high dose response region we will call the Direct Damage Region as
Brenner et al. (2001) has done in his BaD bystander model and we have
done in our prior publications.
2.2 Models for Adaptive Response Dose Response Behavior and Combined
Bystander and Adaptive Response Behavior
In the following sections we will provide a summary of the adaptive
response Microdose Model (Leonard 2007a, 2007b) and a composite
adaptive response and bystander Microdose Model (Leonard 2008a,
2008b, Leonard and Leonard 2008). These will be used in the Appendix
A and the Results sections to examine combined BE and AR effects rela-
tive to human lung cancer risks from radon.
2.2.a Adaptive Response Suppression of Cellular Damage
Since the adaptive response effect involves the micro-dosimetric
induction of a radio-protective behavior in cells from the passage of small
numbers of radiation induced charged particles through the cell, we have
earlier developed the adaptive response Microdose Model (Leonard
2005, 2007a, 2007b). As Equation (1) below, we provide a modified form
of the AR Microdose Model from Leonard (2007a):
Dose Response = DR = Pspon { [ 1 - Pprot-s∞ PAFS (M,N) ]
+ [ 1 - Pprot-r∞ PAFR (M,Q ) ] f(M) PAFD (M,U) ( α D + β D2 ) } (1)
where Pspon is the zero dose natural spontaneous damage, Pprot-s∞ and 
Pprot-r∞ are the adaptive response protection fractions for the reduction of
the spontaneous and radiation induced damage. Broad beam exposures
are assumed to deliver Poisson distributed cellular events (Brenner et al.
2001, Miller et al. 1999, Little and Wakeford 2001, Little 2004). The f(M)
is the AR dissipation function in the Direct Damage Region. PAFS, PAFR
and PAFD are the Poisson accumulation functions for the transition of the
adaptive response spontaneous, the radiation damage protection and the
deleterious direct damage, respectively, given by
n n
PAF (M,n) = 1 - Exp (-M) Σ Mn-γ / (n-γ)! = 1 - Σ P (M,j) (2)
γ=0 j=0
In this general form for the Poisson accumulation function, M is the
mean number of events occurring (such as cell hits) from the radiation
dose and n is the number of incidental events (hits) necessary to produce
the effect (in our case cell radio-biology endpoints). It is important to
note that M is the mean number of events for a statistically significant
B. E. Leonard and others
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large cell population and is not an integer but a continuous function of
dose. The linearity of M as a function of dose is given by M = D / <z1> (so
in our prior formulation and here, M is equivalent to Brenner et al.
(2001) <N>). <z1> is the conventional microdosimetry specific energy
deposition per charged particle traversal through a cell (ICRU 1983) and
defined in Section 2.3.b of Part I. For microdosimetric hits then P(M, j)
is the hit probability at a value of M in the differential range dM that the
required j hits have occurred. Thus, the first term in adaptive response
Equation (1) is the initial zero dose natural spontaneous damage with
adaptive response reduction and the second term is the direct radiation
damage [the conventional linear-quadratic behavior - ( α D + β D2 ) ] with
also a possible threshold and adaptive response radioprotective reduction
as was found to be the case in prior work. We see at zero dose, D = 0, then
M = 0, PAFS (M,N) = PAFR (M,Q) = PAFD (M,U) = 0 and DR = Pspon.
As is frequently the case for risks reported by the Radiation Effects
Research Foundation for the Japanese A-bomb survivor data, we wished
to express the relative risk, RR, (normalized with respect to zero radiation
dose natural spontaneous risk - Pspon) we obtained
RR = DR/Pspon = { [ 1 - Pprot-s∞ PAFS (M,N) ]
+ [ 1 - Pprot-r∞ PAFR (M,Q ) ] f(M) PAFD (M,U) ( α D + β D2 ) / Pspon } (3)
This corresponds to the prior work Equation (16) of Leonard
(2007a) and Equation (19) of Leonard (2008b). We see that for absorbed
dose = D = 0, then M = 0 and RR = 1.0. BEIR VI (1999) makes use of
Relative Risk in evaluating lung cancer risks as seen in Figure 1C of Part
I. These adaptive response Microdose Model parameters are also explic-
itly defined in Appendix B.
2.2.b The Combined Adaptive Response and Bystander Model
We review the formulation of the composite BE and AR Microdose
Model (Leonard 2008a, 2008b). The radiation dose response is expressed
in terms of charged particle traversals through the exposed medium
using Specific Energy Hits as the independent variable. The experimen-
tal radio-biologists conduct their experimental exposures in terms of tis-
sue absorbed dose. However, in planning and analyzing results, the inde-
pendent variable Specific Energy Hits per Nucleus is important, given by
tissue absorbed dose D / <z1>. We here have therefore provided, as was
done in prior work, the BaD Model and our composite AR and BE
Microdose Model in terms of both of these independent variables – and
also, as will be seen, provide the abscissa of our graphs with both. For the
composite model and the BaD Model, we have assumed that there are no
intracellular interactions between the separate processes creating the
potentially deleterious (or protective) bystander and the potentially pro-
Radon Lung Cancer, Bystander, Adaptive Response
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tective adaptive response mechanisms. The composite model encompass-
ing both processes can be given by
Dose Response = Initial Spontaneous Damage (with AR protection) +
Bystander Effect Damage (with AR protection) + Direct Deleterious
Damage (with AR protection)
As defined above, the zero dose natural spontaneous damage is given
by Pspon, as in Equation (1). Thus, from Equation (3), we have for the nor-
malized relative risk as a function of tissue absorbed dose, RR = Dose
Response / Pspon and
B. E. Leonard and others
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FIGURE 1. Examples of adaptive response radio-protection from low LET priming doses for “chal-
lenge” and spontaneous cellular damage as analyzed with the AR Microdose Model (Leonard 2005,
2007a, 2007b, 2008c). Provided as red solid curves are the Poisson accumulations of single charged
particle traversals (Pprot-pr) are shown to induce the protection. Specific energy hits per nucleus abscis-
sa scales are given. Panel A – Wiencke et al (1986) data for relative chromosome aberrations in vitro
versus tritiated thymidine concentrations as the primer source. Data is for a “challenge” dose of 1.5
Gy of 250 kVp X-rays. Panel B – Azzam et al (1996) adaptive response data for 10T1/2 cells exposed
to priming doses of 60Co gamma rays producing a reduction in spontaneous neoplastic transforma-
tions. Panel C – Redpath et al (2001, 2003) adaptive response reduction of spontaneous transforma-
tions from exposure of HeLa x skin cells to primer doses of 137Cs gamma rays. Panel D – Elmore et
al (2005) adaptive response reduction of spontaneous transformations from exposure of HeLa x skin
cells to primer doses of 232 MeV protons. 
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RR( D, N, Q, U) = [ 1 - Pprot-s∞ PAFS (M,N) ] + σ [ 1 - Exp (- k D) ] 
Exp (- ξ q D) / Pspon + [ 1 - Pprot-r∞ PAFR (M,Q ) ] f(M) PAFD
(M,U) ( α D + β D2 ) / Pspon (4)
where M = D / <z1>. Again for absorbed dose = D = 0, M = 0 and RR = 1.0.
From Equation (2) of Leonard (2008a) and Equation (34) of Leonard
(2008b), the BaD Model in terms of tissue absorbed dose is given by
TF = γ q D + σ [ 1 - Exp (-k D) ] Exp (- q D) (5)
In both Equations (4) and (5), the BaD Model parameters q and k are
converted to dose units by q = q / <z1> and k = k / <z1>. Note that we do
not have the BaD model Direct Damage term, γ q D, in Equation (4) since
we have the linear-quadratic Direct Damage dose response term, ( α D +
β D2 ), already in the AR portion of the composite model. Further, <N>
and M are equivalent such that ( D /< z1 > ) = < N > and M in units of
charged particle tracks (hits), So the first term, [ 1 - Pprot-s∞ PAFS (M,N) ],
is the normalized natural spontaneous damage including reduction by
Adaptive Response radio-protection; the second term, σ [ 1 - Exp (- k D) ]
Exp (- ξ q D) / Pspon, is the normalized Bystander Damage part from the
BaD model and the third term, [ 1 - Pprot-r∞ PAFR (M,Q ) ] PAFD (M,U) (
α D + β D2 ) / Pspon, is the normalized (to the initial spontaneous level,
Pspon) direct linear-quadratic response (deleterious Direct Damage)
including adaptive response radio-protection of this damage (by the
Poisson PAFR function) and a possible Poisson accumulated threshold for
the initiation of this direct damage (PAFD). The N, Q and U are the spe-
cific energy thresholds for the Poisson distributed activations.
The Relative Risk, for the composite model in terms of Specific
Energy Hits per Nucleus as the independent variable, is given by
RR( M, N, Q, U) = [ 1 - Pprot-s∞ PAFS (M,N) ] + σ [ 1 - Exp (- k M) ] 
Exp (- ξ q M) / Pspon + [ 1 - Pprot-r∞ PAFR (M,Q ) ] f(M) PAFD
(M,U) [ ( α M <z1>) + ( β M2 <z1>2 ) ] / Pspon (6)
Here if M = 0, then absorbed dose = D = 0 and RR = 1.0.
2.3 Properties of Adaptive Response and Bystander Effects Relative to
Combined High and Low LET Exposures
In the following sections, the experimentally observed properties of
adaptive response and data relative to combined low LET and alpha par-
ticle dose response, based on prior observations, will be summarized .
From the extensive BE data available, the basic properties of BE are exam-
Radon Lung Cancer, Bystander, Adaptive Response
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ined in Part I (Leonard et al. 2009a). The basic behavior of AR with
respect to lung exposure from natural background and man-made low
LET radiations is examined here in Appendix A.
2.3.a Examples of Adaptive Response Protection for Challenge Dose and
Spontaneous Cellular Damage with low LET Priming Doses
In our microdosimetry work (Leonard 2005, 2007a, 2007b, 2008a,
2008b, Leonard and Leonard 2008), we have shown, in the Adaptive
Response data of others (Azzam et al. 1996, Elmore et al. 2006, 2008, Ko et
al. 2004, Redpath et al. 2001, 2003, Redpath and Antoniono 1998, Shadley
and Wiencke 1989, Shadley and Wolff 1987, Shadley et al. 1987, Wiencke
et al. 1986, Wolff et al. 1989) for a number of cell species, that single (i.e.
just one) charged particle traversals through the cell nucleus can activate
AR protection. The early works studied the effects of prior priming doses
on subsequent exposures to larger challenge doses for human lymphocyte
cells (Wiencke et al. 1986, Shadley and Wolff 1987, Shadley et al. 1987,
Shadley and Wiencke 1989, Wolff et al. 1989). Figure 1A provides the AR
data of Wiencke et al. (1986) where the human lymphocyte cells were
treated with endogenic tridiated thymidine and then exposed to the exo-
genic 250 kVp X-rays. Shown is the fit of the AR Microdose Model show-
ing, with the Beta Ray Specific Energy Hits per Nucleus scale, that the
emission of a single low energy tritium beta ray activates the suppressive
radio-protection and reduction of the cellular damage from the challenge
X-rays. Relative to spontaneous AR protection, we show as Figure 1B the
adaptive response data of Azzam et al. (1996) for exposure of 10T1/2 cells
to low priming doses of 60Co gamma rays and subsequent reduction in the
spontaneous transformation frequency. As Figure 1C, we show the AR data
of Redpath and Antoniono (1998) and Redpath et al. (2001) for exposure
of HeLa x skin cells to low priming doses of 137Cs gamma rays and, in this
case, subsequent reduction in the spontaneous transformation frequency
levels. The Microdose Models analysis, in these figures, shows that single
radiation induced charged particle traversals through the cell nucleus ini-
tiates a Poisson accumulated AR radio-protection shown in red in the fig-
ures. This can be seen by referring to the Specific Energy Hit per Nucleus
abscissa scales. As Figure 1D, we show the HeLa x skin dose response to
cosmic high energy (232 MeV) protons (Elmore et al. 2005). In Figure 2,
it is shown, as was extensively analyzed in Leonard and Leonard (2008),
that the mammogram and diagnostic X-rays extend their protection into
the Bystander Damage Region (below one specific energy hit) forming a
double “U” shaped dose response. The mammogram results are signifi-
cant for the millions of women undergoing mammogram screening each
year (Redpath 2007, Redpath and Elmore 2007, Redpath and Mitchel
2006). Altogether, the Dr. Redpath research group has shown that the
adaptive response protection is independent of the type of low LET radia-
7
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tion, encompassing 137Cs gamma rays, mammogram 30 kVp X-rays, diag-
nostic 60 kVp X-rays, 125I brachytherapy photons and 232 MeV protons as
well as 250 kVp X-rays (Shadley et al. 1987), 60Co gamma rays (Azzam et al.
1996) and tritium beta rays (Wiencke et al. 1986), all requiring only one
charged particle traversal through the cell nucleus [see Table I, Leonard
and Leonard (2008)].
2.3.b Combined Bystander Effect and Adaptive Response Effects for Low
LET Radiation
As shown in Figure 2, there are now two spontaneous data sets that
show that low LET radiation can activate a protective bystander behavior
i.e. a reduction at very low doses where the dose is too low for even single
charged particle traversals to have occurred. This is for both the mam-
mogram (Ko et al. 2004) mentioned above and also diagnostic (Redpath
FIGURE 2. Examples of both protective bystander and adaptive response radio-protection reduction
in spontaneous neoplastic transformations. Panel A – Exposure of HeLa x skin cells to 28 kVp mam-
mogram X-rays. Panel B – Exposure of HeLa x skin cells to 60 kVp diagnostic X-rays. 
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et al. 2003) X-rays for HeLa x skin cells as analyzed with the Microdose
Model (Leonard and Leonard 2008). It may be that the other radiations
AR data for HeLa x skin would have shown protective bystander effects
but the exposure levels of the dose sets were not low enough to encom-
pass the Bystander Damage Region [see again Table 1, Leonard and
Leonard (2008)]. Figure 2A and 2B provides these mammogram and
diagnostic X-ray data showing the reduction in dose response at specific
energy hit levels below one traversal (hit) per cell nucleus (thus protec-
tive bystander behavior).
2.3.c Low LET Adaptive Response Radio-protection for High LET Alpha
Induced Bystander Damage
The alpha particle micro-beam research, primarily at the Columbia
University Micro-beam Facility (Randers-Pehrson et al. 2001), has shown
that alpha particles can induce damage to neighbor bystander cells. The
analysis presented in Part I (Leonard et al. 2009a) conclusively supports
this evidence. Recent measurements have shown the range of the
bystander signal from alpha particles in three dimensional tissue is on the
order of 200 µm, which would extend over many lung bronchial and
bronchiolar neighbor cell diameters (Belyakov et al. 2005, Leonard
2009). Of fundamental interest is whether the bystander damage, thus
known to occur in the lung, can be modulated by adaptive response
induction with accompanying low LET radiation. Zhou et al. (2003, 2004)
performed micro-beam alpha particle exposures where 10% of the AL
cells were irradiated with one alpha particle. A significant bystander dam-
age was observed. As a second experiment, 4 hours prior to alpha irradi-
ation, the cells were subjected to broad-beam exposures of low priming
doses of 250 kVp X-rays. Figure 3A shows the relative response and
approximately a 75% reduction in the bystander damage from the alpha
irradiations induced by the low LET X-rays. We also show in Figure 3A the
Azzam et al. (1996) AR data for 60Co priming dose exposures, as a com-
parison, showing nearly the same large magnitude of AR protection.
Again with the micro-beam facility, Sawant et al. (2001a) injected exact
numbers of alpha particles through the nuclei of 10% of the C3H 10T1/2
cell population and measured the clonal survival. As a second experi-
ment, they exposed all the cells to a broad-beam exposure of 2 cGy of 250
kVp X-rays prior to the micro-beam alpha exposures. Figure 3B provides
the percent survival data showing about a 50% adaptive response reduc-
tion in cell killing from the priming dose AR protection.
In the medium transfer experiment of Iyer and Lehnert (2002) the
surviving fraction was measured for the exposure of human lung fibrob-
last to radon alpha particles. As the second experiment, they exposed
supernatant medium to 1 cGy of X-rays and then transferred to the in
vitro culture before alpha irradiation. As seen in Figure 3C, what was
9
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observed was a very large reduction in cell killing even greater than that
observed by Sawant et al. (2001b).
A study was conducted by Wolff et al. (1991) to examine the effective-
ness of 250 kVp X-rays in inducing adaptive response radio-protection for
challenge doses of radon alpha particles in human lymphocyte cells. Cells
were exposed to a dose of 16.4 cGy of radon alphas alone. In a second
experiment, the cells were first exposed to 2 cGy of X-rays and then 15.3
cGy of radon alphas. A 51% decrease in the yield of chromosome aber-
rations was observed.
We had mentioned in our earlier work, the possibility that the human
lymphocyte exposures of Pohl-Ruling (1988) to radon alpha particles may
have exhibited a combination bystander effect and an adaptive response
modulation in the plateau region of her observed dose response curve
FIGURE 3. Examples of adaptive response reduction of alpha particle cellular damage from priming
doses of low dose radiations. Panel A – Shown are the data of Zhou et al (2003) from their study of
adaptive response effects on the micro-beam induced bystander damage to 10% of 10T1/2 cells. The
bystander damage was normalized to damage without priming dose X-rays. We show the reduction of
the bystander damage from priming doses of X-rays. Shown also as a comparison is the data of Azzam
et al (1996) presented in Figure 4B. Panel B – The surviving fraction data of Sawant et al (2001a,
2001b) for injection of specific numbers of alpha particles, showing a reduction in cell killing for
C3H 10T1/2 cells when pre-exposed to X-rays. Panel C – The results of Iyer and Lehnert (2002)
alpha particle exposures where prior exposure of super-nutriants to X-rays produces reduction in
alpha particle human lung fibroblast cell killing. Panel D – The Pohl-Ruling (1988) non-monotonic
dose response of chromosome aberrations in human lymphocytes from radon alpha particles, caused
by adaptive response radio-protection from radon progeny beta rays. Reproduced from Leonard
(2008a) with permission. 
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(see Figure 4, Leonard 2007a). In our more recent work (see Figure 4,
Leonard 2008a), her data was fitted to the bystander BaD Model but the
model was unable to justify the depth of the “U” shaped plateau response.
This in contrast to excellent fits for the data considered in Part I (Leonard
et al. 2009a) and the other bystander data examined in Leonard (2008a).
A detailed analysis of the Pohl-Ruling (1988) data and progeny beta acti-
vation of adaptive response is given in Leonard (2008a). In considering
the 8 different energy beta rays emitted in the 222Rn decay chain, it was
found that enough beta radiation was present for at least one beta tra-
versal per human lymphocyte cell nucleus in the higher radon plateau
region. Figure 3D shows the magnitude of the adaptive response reduc-
tion to produce the non-monotonic behavior “U” shaped dose response.
For the Pohl-Ruling (1988) data, the radon alpha damage may thus be
considered a “challenge” dose behavior and the accompanying radon
progeny betas considered a primer to induce AR protection but with the
beta “priming” dose increasing along with the radon progeny “challenge”
alpha dose until just enough beta ray traversals occur to induce adaptive
response. This implies that human lung tissue may be subjected to adap-
tive response reduction in lung cancer risk from the radon progeny own
beta radiation that may dominate over the bystander chromosome dam-
age. One may question the validity of this beta ray protection since it will
occur simultaneous with the progeny alpha damage and not a priming AR
dose hours before. as seen to be the case from the work of Shadley et al.
(1987) [see Figure 1C, Leonard (2007b)]. Two factors are at play in the
beta AR protection. One is that many more cells are traversed by the low
LET betas than hit by the short range alphas rendering them protected
during the approximately 30 day mitotic cycle for lung cells. This is dis-
cussed Section 3.2. Also, there is evidence that AR protection may be acti-
vated after the challenge dose (Day et al. 2007a, 2007b). We will consider
these radon progeny betas as one low LET radiation source of adaptive
protection against lung cancer in later Section 3.1.e.
2.3.d The Time Dependent Behavior of Adaptive Response Radio-protection
– Fading and Dose Rate Effects
Shadley and Wiencke (1989) studied the sensitivity of adaptive
response protection with respect to the dose rate of the priming dose for
challenge dose experiments with human lymphocytes using 250 kVp X-
rays. In evaluating their data, it was found that there is a dose rate thresh-
old as well as a single traversal dose threshold (Leonard 2005, 2007b).
Elmore et al. (2006) measured the dose rate behavior of adaptive response
for spontaneous damage in HeLa x skin cells, which we examined with the
Microdose Model in Section 3.1 of Leonard (2008b) with again a dose rate
threshold being required to model the data. Shadley et al. (1987) varied
the time between the administration of the priming dose and the later
11
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challenge dose. It had been known from others that the endogenic cellu-
lar activation of the AR radio-protection required 4 to 6 hours. From
Leonard (2007b), we reproduce the Figure 1C graph as Figure 4A here of
the adaptive response protection afforded the challenge dose as a func-
tion of time between the priming dose and the challenge dose. It is shown
that the protection is maintained at a constant level up to 38 hours but
then begins to fade and the protection is dissipated. The cell cycle time for
human lymphocytes is approximately 38 hours. Considering the dose rate
threshold also being compatible with the cell cycle time, the data suggests
that the protection may be lost at mitosis although this has not been con-
clusively confirmed in the laboratory. The fact that after the AR activation
Radon Lung Cancer, Bystander, Adaptive Response
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FIGURE 4. The persistence and fading of adaptive response radio-protection. Panel A – From
Shadley et al (1987). The normalized reduction in relative chromosome breaks as a function of delay
time between administering of the 1.5 Gy X-ray “challenge” dose after the 1.0 cGy primer dose. The
AR protection is shown to materialize in about 4-6 hours and is sustained for about 38 hours before
fading and completely dissipating. Panel B – The data of Klokov et al (2000) showing reduction of
mice bone marrow micronuclei after exposure in vivo to X-rays as a function of time after exposure.
Both reproduced from Leonard (2007b) with permission. 
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threshold and Poisson transition of the AR protection, the protection
remains constant as primer dose is increased (as seen in Figure 4A) sug-
gests that early stages of the cell cycle may be insensitive to AR activation
and the magnitude of the protection, when it becomes fully effective, is
related to the fraction of time in the entire cell cycle that the cell is sensi-
tive to the single charged particle traversal that produces the activation.
Other data however contradict the mitosis AR dissipation hypothesis.
Klokov et al. (2000) found that exposure of the SHK mice in vivo to low
doses between 0.1 and 0.4 Gy produced a reduction in bone marrow
micronuclei that was sustained for up to 100 days. We show their data as
Figure 4B. We will discuss other very recent data, primarily from Dr. Ron
Mitchels research group (Mitchel et al. 1999, 2002, 2003, 2004, Mitchel
2006, 2007a, 2007b, 2008), showing the persistence of AR effects in vivo for
much longer times in the later Discussion sections of Part III (Leonard et
al. 2009b). It may be that AR is sustained longer in vivo than in tissue cul-
tures where immortalized cells are used.
2.3.e The Dose Region of the Dose Response Curve for the Adaptive
Response Radio-protection to be Effective
We have divided the basic dose response curve into three regions i.e.
the Bystander Damage Region, the Adaptive Response Region and the
Direct Damage Region as shown in Figure 2. Of significant interest is the
questions of “at what dose level does the AR protection begin and at what
dose level does the deleterious Direct Damage begin to dominate over
the protection and also what role does the quality of the radiation plays?”.
The dose region of low LET radiation exposures, where humans may
expect adaptive response radio-protection, depends on the size of the
energy deposition for the single specific energy hits that are found to first
begin to activate AR. We have compared the AR behavior of HeLa x skin
cells for 137Cs 0.66 MeV gamma rays and the much lower energy 28 kVp
mammogram X-rays in Figure 5. In earlier work, we examined the differ-
ences in the initiations of the adaptive response radio-protections and the
beginning of the Direct Damage domination at higher doses (Leonard
and Leonard 2008). The question is “At what dose or charged particle tra-
versals does the Direct Damage begin to dominate over the AR protec-
tion?” In Figure 5A, the abscissa scale is in units of Primer Absorbed Dose
where we show for both radiations that the Direct Damage component
begins to dominate at a threshold of about 10 cGy but the lower dose
thresholds for AR activation is quite different for the two radiations, in
terms of dose. In Figure 5B, we use Primer Specific Energy Hits per
Nucleus as the abscissa scale and we see that the lower dose AR thresholds
coincide at a mean of one specific energy hit per nucleus but the begin-
ning of the Direct Damage component is over a factor of 10 different in
terms of hits. This is because the respective values of <z1> (which deter-
mines the AR single hit threshold) are quite different i.e. 0.638 cGy/hit
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FIGURE 5. Comparing the Ko et al (2004) mammography data and the Redpath et al (2001, 2003)
137Cs data. Panel A – the simultaneous plot of the two data sets and Microdose Model fits as a func-
tion of Primer Absorbed Dose. We see that the two high dose Direct Damage curves very nearly coin-
cide even though the LET’s and <z1> values are very different, indicating the total energy deposited
to the cells dictates the priming dose induced high dose Direct Damage response, not the Specific
Energy for each hit. Panel B – Plot of the data and fits as a function of accumulated Primer Specific
Energy Hits per Nuclei. We see that, as determined from our Microdose Model analysis, that a
Poisson distributed mean of one single Specific Energy Hit activates the Adaptive Response protec-
tion. This means that Adaptive Response activation is solely dependent on a single Specific Energy
Hit irregardless of the size of the energy in the deposition and independent of the Primer Absorbed
Dose. Panels A and B reproduced from Leonard (2008b) with permission. Panel C – Reproduction
of Redpath and Elmore (2007) Figure 1 with permission. Analysis of their combined data for 137Cs
gamma rays, 28 kVp X-rays, 60 kVp X-rays, 232 MeV protons (Redpath et al 2001, Redpath et al 2003,
Ko et al 2004, Elmore et al 2005) showing a threshold and linbearity of the Direct Damage dose
response. Shown also is an apparent retention of the AR protection in the Direct Damage Region. 
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and 0.060 cGy/hit for the mammogram X-rays and the 137Cs gamma rays
respectively. We have found that the constancy of the Direct Damage
threshold persists, in terms of dose, for the other radiations used by Dr.
Redpaths group. In fact, Redpath (2007) showed this to be true in ana-
lyzing the dose response slopes of the different results for high and low
spontaneous level AR experiments. We reproduce their Figure 1 as Panel
C of Figure 5. This means that the dose range for the AR protection is
shorter for radiations with higher <z1> value i.e. lower energy radiations,
with correspondingly higher LETs. No data has shown adaptive response
radio-protection being induced by naturally occurring alpha particle
radiations, the lack of this then as evidenced from our Part I analysis. This
may be because the <z1> values range from about 5 to 20 cGy/hit – in the
region for the Direct Damage threshold, negating any observable evi-
dence of AR by domination of the Direct Damage.
2.3.f The Potential Retention of the Adaptive Response Radio-protection at
High Dose Levels in the Direct Damage Region.
Microdose Model analysis of dose response data have shown that a
threshold seems to exist for the induction of the Direct Damage as dose
increases when AR protection is present. Some data also show that the
adaptive response protection is retained at the higher doses above the
Direct Damage threshold. This has been examined in Figure 1D, 2 and 3C
of Leonard and Leonard (2008). AR retention is seen to occur if, by extrap-
olation of the Direct Damage, linear- quadratic, region back to the origin
of the dose response curve, the extrapolation intersects below the zero
dose spontaneous level. The Figure 5C here of Redpath et al. (2001) shows
an extrapolation well below the spontaneous level for all their AR data, thus
showing AR retention even at doses where the Direct Damage dominates.
2.4 The Human Lung Cells as “Targets” for Low LET Traversals and
Subsequent Energy Depositions per Traversal
2.4.a The Size of the Human Lung Target Cells Susceptible to Carcinogenesis
Section 2.3.a of Part I discusses the estimated size of the three lung
“target” cell species susceptible to carcinogenesis. They are the bronchial
basal, bronchial secretory and bronchiolar secretory lung cells and each
vary in size and hence present different target sizes for radiation “Hits”
for the radon progeny alpha particles and the low LET AR inducing radi-
ations. This thus affects the value of <z1> and cell hit rates relative the
exposure doses. For our analysis. we estimate the three cell diameters to
be 9.0, 17.7 and 10.7 µm for the bronchial basal, bronchial secretory and
the bronchiolar secretory cells, respectively. These are in agreement with
the BEIR VI (1999) Table 2-1 data and the same data used by Little and
Wakeford (2001). We use these diameters in Tables A1, A2 and A3 of
Appendix A to estimate the Specific Energy Deposition per Nucleus
B. E. Leonard and others
516
15
Leonard et al.: Radon Lung Cancer, Bystander, Adaptive Response
Published by ScholarWorks@UMass Amherst, 2014
Radon Lung Cancer, Bystander, Adaptive Response
517
Traversals for the low LET radiations received by the lung from human
exposures at the UNSCEAR (2000) world average low LET human expo-
sure levels (Table 1 herein).
2.4.b Method for Determination of the Mean Specific Energy per Sensitive
Volume Hit - < z1 >
Section 2.3.b of Part I provides the means to determine the micro-
dose parameter Specific Energy Deposition per Charged Particle
Traversal, <z1>. It is dependent on the linear energy transfer, LD (in units
of keV / μm ) and the mean chord length,  (in units of μm ), traversed
through the sensitive volume. As was the case in the earlier works
(Leonard 2005, 2007a, 2007b, 2008a, 2008b, Leonard and Leonard 2008)
the sensitive volume here is chosen to be the nucleus for the three human
lung cell species. BEIR VI (1999), ICRP (1995) and James et al. (2004) in
their analysis with respect to alpha particle traversals consider the nucle-
us as the sensitive region for lung cancer induction. We noted in Section
2.3.a of Part I, by considering the mean chord length per cell cross-sec-
tion area, an analytical approximation for <z1> was offered by Kellerer
and Rossi (1972) as a function of spherical critical volume diameter, d,
and the dose-averaged linear energy transfer, LD, of the radiation, i.e.
<z1> = 22.95(cGy g keV
-1 per chord length-μm)LD / ρ d2 cGy 
per Hit (nucleus traversal) (7)
where ρ = density of cell tissue.
We estimate the accuracy in determining the cell nucleus diameters
to be about ± 20 %SD and the overall accuracy of <z1> to be ± 30 %SD
due to uncertainties in Le also. The impact of this on the use of the
model is addressed in Leonard (2008b).
2.5 The Methods for Assessing the Combined Influence of the Bystander
Effect and Adaptive Response on Human Lung Cancer Risks
1. In Section 2.3 above, we showed that all types of low LET ionizing
radiations will activate the adaptive response radio-protection within
cells, from single charged particle traversals through the nucleus. It is
necessary to identify all the low LET whole body radiations and amount
of dose from each to lung tissue.
2. To determine the charged particle track accumulation in the lung
tissue, we will evaluate the new knowledge that has been gained about
both 1.) the bystander effect and general cellular response to alpha par-
ticle radiation in Part I (Leonard et al. 2009a) and 2.) the protective
behavior of adaptive response as reviewed here in the above Section 2.4.
As was done in the recent prior works (Leonard 2008a, 2008b, Leonard
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and Leonard 2008), we will use the composite Adaptive Response and
Bystander Effect Microdose Model, presented in detail in Leonard
(2008b) and reviewed above, to examine and evaluate the expected
behavior in the human lung.
With the Microdose Model, we have found that adaptive response has
the very specific behavior, in particular, that single cell low LET charged
particle traversals activates the protection and the protection results in
between 50 and 80% reduction in potentially carcinogenic radiation
induced exogenic cellular damage and endogenic spontaneous cellular
damage. The protection is afforded for alpha particle cell damage as well
as low LET radiation cell damage as shown in Section 2.3.c. The protec-
tion is relatively independent of the type of priming dose radiation qual-
ity, encompassing low and high energy X-rays, beta rays, gamma rays and
even high energy cosmic protons. We have seen in Section 2.3.f that, at
higher doses, the protection may be retained but at about 10 cGy of expo-
sure the excessive damage from the priming dose begins to dominate. In
Section 2.3.d, we showed that the duration of the protection, from dose
rate and fading studies, is at least through one cell mitotic cycle and thus
we will evaluate the charged particle traversals to the lung cells for the 30
day mitotic cycle (James et al. 2004).
3. RESULTS
3.1 General Approach to Assessment
A fundamental unknown, at the time the BEIR VI (1999) report was
drafted was the amount of influence adaptive response has on radon
progeny alpha particle initiation of human lung cancer. We here endeav-
or to assess the magnitude of adaptive response radio-protection that
humans receive from the various low LET radiations received by humans
on a routine, day-to-day basis. Based on the extensive supportive data,
some of which is presented in the prior sections, we assume that single
radiation induced charged particle traversals activates the Poisson transi-
tion of each traversed cell to the adaptive response radio-protective state.
In Appendix A, we first tabulated the low LET radiations that an average
person would receive using the United Nations worldwide average values
for each of the radiation components. The UNSCEAR (2000) worldwide
human exposures are provided in Table 1. In Table A1 of Appendix A,
the radiations are listed with the energies, fraction of decays and the LETs
(Attix 1986) for each radiation component. As was explained above, to
obtain the number of charged particle traversals, the Specific Energy
Deposition per Traversal, <z1>, is required. In Section 2.4.b, using
Equation (7), it is shown that the diameter of the “target” cell as well as
the LET of the radiation is needed. In Table A2, the LETs and the cell
diameters of the three sensitive lung cells, bronchial basal, bronchial
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secretory and bronchiolar secretory, are given. In Table A2, using the
UNSCEAR (2000) human exposure levels and the calculated <z1> values
for each natural background and man-made radiation component is tab-
ulated. The number of cell traversals (hits) occurring in one cell cycle (30
days) is then tabulated as a final result. These are for the worldwide annu-
al average low LET radiations, giving traversals per 30 day cell cycles, and
at the median radon concentration of 24.3 Bq m-3. In Table A2, we find
that a significant fraction of the lung cells are traversed by single low LET
charged particles and a sizable adaptive response radio-protection must
be present i.e. 28.6%, 72.9% and 37.9% in the three respective cells.
We are interested in evaluating the magnitude of the AR protection
as a function of varying human radon exposure and varying low LET
Radon Lung Cancer, Bystander, Adaptive Response
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human exposures. As noted, there are two lung dose components that
vary with radon concentration. They are 1.) the radon progeny beta ray
dose to the lung, that varies linearly with radon concentration and 2.) the
terrestrial Uranium gamma ray dose which we have evaluated from USGS
data and some indoor gamma ray measurements and presented in the fol-
lowing sections. By conservatively assuming the other human exposure
components remain at the worldwide averages, we have estimated the
variation in lung cell traversals with increasing radon concentration. As
Table A3, we show a section (for Basal lung cells) of the spread sheet used
to tabulate the Specific Energy Hits to the lung cells as a function of
increasing radon concentration.
3.2 Effectiveness of Low LET Radiations in Providing Single Charged
Particle Traversals to Lung Tissue
Humans receive a substantial amount of low LET ionizing radiations
from natural background and man-made radiation sources. In Section
2.3, we have cited numerous radio-biology data showing that cells under-
go a hormesis type adaptive response protective behavior from very low
doses of low LET radiation. It has been shown that single, radiation
induced, charged particle traversals through the cell nucleus activates
this AR protection. It has also been shown that beta rays, X-rays and
gamma rays seem to be equally effective in inducing this AR protection.
This is substantiated by the low energy, 0.0186 MeV tritium beta AR data
of Wiencke et al. (1986), the 28 kVp X-ray AR data of Ko et al. (2004), the
60 kVp diagnostic X-ray AR data of Redpath et al. (2003), the 250 kVp X-
rays AR data of Shadley et al. (1987), the 31-35 keV photons 125I
brachytherapy AR data of Elmore et al. (2006), the 0.66 MeV 137Cs gamma
ray AR data of Redpath et al. (2001), the 1.17-1.33 MeV 60Co gamma ray
AR data of Azzam et al. (1996) and the cosmic ray level 232 MeV proton
AR data of Elmore et al. (2005). The range of low LET values that span
these radiation sources is from about 0.1 to 2.0 keV/µm and the range of
Specific Energy Depositions per Cell Nucleus Traversal, <z1>, is from
about 0.02 to about 1.0 cGy/hit. The transmission range in tissue is from
about 0.01 to 1.0 cm and therefore a 1 MeV photon produced electron or
a beta ray will traverse many cell diameters compared to the µm range
alpha particles in tissue. Figure 2-1 of BEIR VI (1999) illustrates the large
difference in tracks for 1 Gy of low LET tracks (1000 tracks) to high LET
alpha particles (4 tracks). We provide as Figure 6, a chart relative to beta
or photon producing electrons and alpha traversals. Shown in the upper
section are the effects from low LET radiation, 10 MeV protons and 4 Mev
alpha particles in terms of LET and number of cells traversed. In the
lower section, specifically for radon progeny beta rays and the 7.69 MeV
214Po radon progeny alphas, we give the range in tissue, the LET and <z1>
showing a considerably lower dose of the radon progeny beta rays is capa-
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FIGURE 6. Top Panel - Graphics showing the difference in tissue interactions of low LET radiation
induced charged particles and high LET alpha particles. Bottom Panels – Left, Alpha particle fluence
as a function of distance through human lung tissue. Right, Location of basal and secretory cells
depth in human lung tissue. 
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ble of delivering the necessary single charged particle traversal to the
lung cells to induce AR protection against chromosome damage inducing
lung cancer. The radon progeny are deposited on the interior lung air
passage surfaces, and become located primarily in the mucous gel and
cilia regions [see Figures 9-2 through 9-5 of NRC (1991)]. In the lower
two panels of Figure 6, we reproduce graphs of Nikezic and Yu (2001)
that show the relative location of the basal and secretory cells relative to
the radon progeny. The average alpha particle emitted from the progeny
is attenuated by at least 50% before reaching the three cancer sensitive
cells. The attenuation of the progeny beta rays is negligible. Strictly from
an energy deposition basis, the total beta disintegration energy is 2.12
MeV, from Figure A2 and Table A1. The total energy of the two alpha par-
ticles is 6.00 + 7.69 = 13.69 MeV. If 50% is lost by attenuation then the
deposition energy of the betas to the target cells is about 31%. Thus the
progeny beta rays contribute a significant amount of low LET radiation,
and potential adaptive response protection, to the sensitive lung tissue.
3.3 Properties, Magnitudes and Variations of Radiation Sources to Humans
3.3.a Sources of Low LET Radiations Experienced by Humans
In Table 1 and Section 3.3.a.1 below, we identify the various compo-
nents to the radiations received by humans, for the purpose of assessing
the AR inducing low LET radiations to the human lung that can activate
adaptive response radio-protection to the lung cells and affect the risk
probabilities of human lung cancer from radon progeny alpha particles.
We then, in Appendix A, used the United Nations world-wide average
exposure rates (UNSCEAR 2000) of these low LET components, given in
Table 1, to estimate the low LET charged particle traversals to the three
most sensitive lung cells i.e. bronchial basal, bronchial secretory and
bronchiolar secretory cells, for potential AR activation. Then the special
effects like the statistical distributions of these world-wide averages, from
variations in geological and ecological conditions, are considered with
respect to a high and low range of human exposure to these AR inducing
charged particle traversals. The variations of, for example, U series ter-
restrial dose and beta radon progeny dose with radon indoor concentra-
tion are considered.
3.3.a.1 World-wide Averages of Human Low LET Exposures
Americans receive a population averaged annual dose equivalent of
about 2.4 mSv of background radiation of which 39 % is low LET, consist-
ing primarily of about 20% terrestrial gamma rays, 12% a cosmic ray com-
ponent and 7% internal (ingestion) component, and 52 % from high LET
radon progeny (BEIR VII 2006). We also receive an annual average of
about 0.5 mSv of man-made radiation, of which at least 98 % is low LET.
Thus, the major components of our total population averaged annual
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dose of 2.9 mSv is about 1.44 mSv low LET and about 1.25 mSv high LET
radon progeny alphas. The United Nations Scientific Committee on the
Effects of Atomic Radiation (UNSCEAR 2000) provides slightly different
values for world-wide averaged human exposures and provides a more
detailed break-down of the various components (summarized in Table 1).
They estimate the external exposure from cosmic rays to be 0.3 mSv for
the directly ionizing component and 0.055 mSv for cosmic neutrons. The
internal cosmogenic dose is about 0.010 mSv. From external natural
radioactivity exposure, they estimate 0.15 mSv for 40K, 0.100 mSv for the
238U series and 0.160 mSv from the 232Th series. Internal exposure from
ingestion of radio-isotopes is estimated to be about 0.18 mSv from potassi-
um-40, 0.006 from 87Rb, 0.005 mSv from 238U transition to 234U, 0.007 mSv
for 230Th, 0.007 from 226Ra, 0.12 mSv from 210Pb transition to 210Po, 0.003
from 232Th, and 0.013 from 228Ra to 224Ra. The total annual exposure from
natural sources equals about 0.765 mSv external and 0.356 mSv internal.
UNSCEAR (2000) estimates that humans receive about 0.4 mSv from diag-
nostic medical exposures. Rounded off UNSCEAR (2000) values for the
net components are in their report to the UN General assembly are exter-
nal cosmic rays 0.2 mSv, external terrestrial gamma rays 0.5 mSv, medical
0.4 mSv, internal Ingestion 0.3 mSv and inhalation 1.2 mSv of which 1.1
mSv is considered radon (with a US median of 24.3 Bq m-3 concentration).
Then the non-radon human exposures, which would be about 99% low
LET, is 1.7 mSv per year. There are special considerations relative to the
terrestrial radiations with respect to the relative contributions of the three
components, Uranium series, Thorium series and Potassium-40 and their
indoor distributions. Also, it is known that there is a correlation between
the indoor radon concentration and the Uranium series indoor compo-
nent, which we will address in the next section. Further, as we showed for
the Pohl-Ruling (1988) data in Figure 2D and evaluated by Jostes et al.
(1991), the beta ray dose from the lung deposited radon progeny con-
tributes a significant number of lung cell low LET charged particle traver-
sals that increases with increase in radon concentration. So the world-wide
averages for U series dose and progeny beta dose is coupled to the world-
wide variation in indoor radon concentration.
3.3.b Special Consideration for Terrestrial Radiation Components and
Distributions.
3.3.b.1 Local Variations - USGS and EPA Terrestrial Gamma and Radon
Concentrations
We next examine the variability of the human exposures worldwide
using the UNSCEAR (2000) maximum and minimum range values in
Table 1. In quoting US or world-wide averages for human exposure to
ionizing radiations, usually a statistical range is also given, for example by
BEIR VII (2006) and UNSCEAR (2000). More specific data are provided
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by the United States Geological Service (USGS) for the US lower 48 states
(Duval et al. 1989, Phillips et al. 1993). An extensive program of mapping
the terrestrial radiation components, U, Th and 40K exposures at 1 meter
above ground level has been completed using highly sensitive aerial radi-
ation monitoring equipment. Details relative to the airborne gamma ray
method are found in a NOAA report (NOAA 2008), a DOE report (DOE
2002) and Schwartz et al. (1995). Figure 7 provides four maps of the ter-
restrial Gamma-Ray Exposure at 1 meter above ground. The first panel
shows the net from all three gamma ray sources in units of µR/h (1 R = 1
Roentgen = 0.86 Rad = 0.86 cGy). The other three maps show the gamma
radiation levels for Uranium, Thorium and 40K. The units for U and Th
are parts per million (ppm) and for 40K are %K. To obtain the exposure
dose rates for each and total, the USGS conversion equation is
Total Exposure Rate (nGy/h) = 13.2 (nGy/h per %K) K (%K) 
+ 5.48 (nGy/h per ppm U) U (ppm) + 2.72 (nGy/h per ppm Th) 
Th (ppm). (8)
We show the gamma ray spectra for the three components as Figure
A1 of Appendix A. It is seen that the South-west region of the US shows
the major gamma ray exposure for all three components. The Pacific
North-west and Florida are seen to be the lowest terrestrial gamma ray
exposure regions. Digital reports have been issued by USGS presently for
only the Uranium series gamma ray dose data (in ppm) by counties for
all states, in an Excel spread sheet.
EPA distributed maps are available for geometric mean radon levels
in the US, also. We show as Figure 8A, a map of the geometric mean res-
idential radon concentrations by states in pCi/L units. As Figure 8B, we
provide a map of the US showing by county the mean residential radon
levels in fractions of homes over 4 pCi/L. The EPA High-Radon Project
has also provided in Excel spread sheet format itemized data on individ-
ual radon measurements organized by counties in each state.
3.3.b.2 Local Variations - Special Measurements of Radon and Gamma Ray
Distributions
Relative to the distribution of the terrestrial gamma ray exposures,
the state of California has been mapped and digital data provided by
county has been provided (EPA 2003)). We have analyzed the distribu-
tions of the U, Th and 40K county data and provide these as Figure 9. The
average total terrestrial gamma ray dose rate in California is 53.1 nGy/h.
The respective gamma ray dose rates for the three components, U, Th
and 40K, are 14.3, 18.8 and 20.0 nGy/h. The data has been fit to Normal
Distribution functions with σ’s of 5, 9, and 9.9 nGy/h and standard errors
of 0.8, 0.9 and 1.0 nGy/h, respectively. From another part of the world,
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Clouvas et al. (2001) have preformed detailed indoor radiation measure-
ments in over 1000 Greek homes. They used a high resolution
Germanium gamma ray detector system to resolve the separate gamma
rays from the Uranium, Thorium and Potassium isotopes. Figure 10 pro-
vides their dose rate distributions for the U, Th and K sources. Their
gamma spetra are shown as Figure A1 in Appendix A. We have best fitted
the data more accurately to log-normal distributions than a normal dis-
tribution, however the Potassium data showed a distribution between a
normal and a log-normal. The total mean gamma dose rate was 47.0
nGy/h. The three components dose rates were 14.1, 15.3 and 17.5 nGy/h
for U, Th and K respectively.
Clouvas et al. (2006) recently performed a new survey of Greek homes
where both indoor gamma ray dose rates and radon concentrations were
measured. In a total of 311 homes, the total gamma ray dose rate was
58.33 ±12.15 nGy/h and the three components were 14.61 ±3.80 (U),
20.81 ± 3.78 (Th) and 22.92 ± 4.92 (K) nGy/h. The average radon con-
centration was 34 Bq m-3. The distributions for the total indoor gamma
ray dose rate is shown in Figure 11A and the distribution for the radon
concentration is presented as Figure 11B. The gamma ray data reflects a
Normal Distribution and the radon a Log-Normal Distribution. We show,
for the radon data, the lung cell nucleus traversals for the three sensitive
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FIGURE 7. Reproduction of USGS terrestrial radiation maps (Duval et al 1989) for total gamma ray
exposure and separate exposures from Uranium series, Thorium series and Potassium-40. 
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lung cell species based on James et al. (2004) values given in our Figure
11B. What is shown is that even on a local basis humans are exposed to a
large range of radiation levels from the exposure sources, within the very
large range of mean values worldwide. This means that one would expect
to see a wide range of natural background and man-made radiation
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FIGURE 8. Reproduction of EPA radon maps (EPA 2003) showing indoor radon levels by states and
by counties. 
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FIGURE 9. Analysis of the terrestrial gamma ray data from EPA (2003) for the state of California by
counties providing Normal Distribution for each component and the geometric mean averages.
Panel A – Total gamma ray. Panel B – Uranium series gamma ray. Panel C – Thorium gamma ray.
Panel D – Potassium-40 gamma ray. 
FIGURE 10. Analysis of the frequency distribution data of Clouvas et al (2001) for residential terres-
trial gamma ray exposure showing Log-Normal Distributions and mean values. Panel A – Total
gamma ray. Panel B – Uranium series gamma ray. Panel C – Thorium gamma ray. Panel D –
Potassium-40 gamma ray. 
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induced Adaptive Response radio-protection from the wide range of
radon and progeny alpha induced lung damage as seen in the case-
control studies [see Figure 2 of Part I (Leonard et al. 2009a)].
3.4 Correlation Between Terrestrial Uranium Gamma Ray Dose and Radon
Indoor Concentration
It has been known that the Uranium series indoor gamma ray dose
correlates with the indoor radon concentrations. This is because radon
and its progeny are decay products in the Uranium series. Several inves-
tigators have examined this correlation. Clouvas et al. (2003) performed
a limited study comparing the Uranium series gamma dose rate with
radon levels and found minimal correlation primarily due to a small
number of data sets. Pilkyte and Butkus (2005) obtained measurements
in 609 individual rooms in Lithuania and found considerable scatter in
the data but a linear variation of Total Gamma Absorbed Dose Rate
(nGy/h) = 121.5 nGy/h + 0.03 (nGy/h per Bq m-3) C (Bq m-3) where as
noted C is radon indoor concentration in Bq m-3. We have converted the
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FIGURE 11. Analysis of separate data by Clouvas et al (2001) showing indoor gamma ray dose rates and
indoor radon concentration distributions. Also comparisons of radon concentration (EPA) and terres-
trial Uranium gamma ray dose (USGS), for Arizona Nevada and Missouri, showing large variation in
relative levels for the terrestrial Uranium gamma ray dose depending on geological localities. Panel A
– Clouvas et al (2001) gamma ray data. Panel B – Clouvas et al (2001) indoor radon data showing a Log-
Normal Distribution. Panel C – Radon (EPA 2003) and Uranium gamma ray (USGS) data. 
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linear equation to Annual Gamma Dose in mSv (for gamma rays we let 1
mGy = 1 mSV) and show the curve as a solid blue line in Figure 12A. Also,
Makelainen et al. (2001) examined a possible correlation in homes in
Finland. They also found a loose correlation and found a difference
between wood and masonry constructed homes. Their three data points
for each case (wood and masonry) are shown in Figure 12A. The most sig-
nificant data on indoor gamma ray dose and radon concentration are
Radon Lung Cancer, Bystander, Adaptive Response
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FIGURE 12. Examination of correlation between variation in terrestrial Uranium gamma ray dose
and variation in indoor radon concentration. Panel A – Graphical presentation of U gamma and
radon data from Pilkyte and Butkus (2005), Makelainen et al (2001) and the British Columbia radi-
ation survey (BC 2008). Panal B – The variation of indoor cosmic ray, indoor terrestrial and internal
dose with increasing indoor radon concentration. Panel C – A linear-quadratic least squares fit to the
British Columbia (BC 2008) terrestrial gamma ray dose. 
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that obtained by the Canadian province of British Columbia in a study of
human indoor doses from natural and man-made radiations. The study
was performed by the British Columbia Centre for Disease Control (BC
2008). From the data for 22 provincial territories, we provide, in Figure
12A, the terrestrial annual dose equivalent data is given by sorting with
respect to radon concentration also in mSv. In Figure 12B, we show three
of the components in the British Columbia study (BC 2008) i.e. the cos-
mic ray gamma component which is found to vary slightly with increasing
radon levels, the terrestrial gamma ray dose, the internal dose and the
sum of the indoor gamma cosmic and terrestrial. The sum curve is the
same as shown in Figure 12A. These data show that the terrestrial gamma
ray dose increases with increasing indoor radon concentration. As we
noted, it has been known that the Uranium content found in local soils
and in building materials correlates with indoor radon concentration lev-
els [as suggested by the Makelainen et al. (2001) data and USGS]. The
connection with the Uranium series is because radon and its progeny are
part of the Uranium decay series. A fundamental question is whether the
Potassium-40 and Thorium series show some correlation also. Figure 12C
provides a graph of the variation of U and Th, by ratios, with increasing
observed K-40 levels. We see that the Th gamma ray dose is relatively lin-
ear with K-40 gamma ray dose. The Uranium dose shows significant vari-
ation indicating that the U dose varies with radon concentration where-
as the other two gamma components are relatively constant. For the
British Columbia (BC 2008) data presented in Figure 12B, we can esti-
mate the variation in Uranium with respect to indoor radon levels by
assuming that UNSCEAR (2000) world-wide ratios for U, Th and K-40 are
valid. From the Table I from the UNSCEAR (2000) report, the U, Th and
K-40 values are 0.100, 0.160 and 0.150 mSv, respectively. By assuming that
these relative values apply for BC (2008) at the median radon concentra-
tion of 24.3 Bq m-3 and the Th and K-40 dose equivalents remain constant
at those levels, we obtain the variation in Uranium Dose Equivalent with
radon concentration. We show this in Figure 12D.
In the previous section, we showed how, from location to location, the
radiation levels vary considerably. Another estimation of the correlation
between the Uranium series gamma terrestrial dose and radon concen-
tration was obtained from the USGS Uranium Concentrations Data File by
US counties from the High-Radon Project: (NURE 1986). The data is
given in ppm Uranium. With the 5.48 nGy/h per U ppm conversion fac-
tor [see Equation (9)] the mean Uranium dose equivalent for each coun-
ty is available. To accompany this data, we have used the EPA State
Residential Radon Survey ASCII data (EPA 2003) which lists individual
indoor radon measurements by county in each state. A total of over 51,000
data sets are provided. We have chosen the California and the Idaho state
data sets (EPA 2003) and averaged the radon concentration results for
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each county in these two states. We herein shall refer to these selective data
from EPA (2003) as CA/ID. A total of 1886 indoor radon concentrations
in the 53 counties were used for the California data. For Idaho, there were
1266 radon data sets for the 41 counties. Figure 12E provides the county
averages data points as a function of radon concentration. Shown are also
the separate 5 point smoothed curves, for California and Idaho, and the
data least squares fitted to a linear-quadratic curve. The separate fits were
very similar. For California, we obtained
Uranium Gamma Dose (mSv) = 0.014 + 0.0029 C - 1.9 x 10-5 C2
where C is radon concentration in Bq m-3. For the Idaho data, we
obtained
Uranium Gamma Dose (mSv) = 0.016 + 0.0032 C - 2.1 x 10-6 C2
The purple curve is the averaged composite fit with
Uranium Gamma Dose (mSv) = 0.015 + 0.00305 C - 2.0 x 10-6 C2. (9)
For the over 3000 radon data sets, we find that there is a significant
variation in Uranium gamma ray dose with increasing indoor radon lev-
els. It is significant that, using the median radon concentration of 24.3 Bq
m-3 in the Equation (9), we obtain a Uranium gamma dose of 0.0879 mSv
per year. The UNSCEAR (2000) estimated world-wide value is 7 nGy/h =
0.0964 mSv per year for the low LET gamma rays. It is seen that, at very
low radon levels, the Uranium gamma ray dose is about 1/2 the level at
the mean radon concentration of 24.3 Bq m-3. As Figure 12F, we provide
the British Columbia (BC 2008) and the composite CA and ID Uranium
Gamma Ray Dose Equivalent curves with their estimated standard errors
(EPA 2003). We will use these estimates for the correlation of terrestrial
Uranium gamma ray dose with indoor radon concentration and AR
inducing charged particle traversals for the Uranium gammas with vary-
ing radon concentration.
3.5 Lung Dose from the Low LET Beta Rays Emitted from the Lung
Deposited Radon Progeny
The radon gas and its progeny emit 14 different energy gamma rays
and 7 different energy beta rays as seen in Figure A2. In most instances the
effects of the radon progeny beta and gamma rays have been neglected
when assessing the health risks from radon. This has been true for the
BEIR Committee reports and even a recent extensive analysis by Kendal
and Smith (2002) of doses to the lung and various other human organs
and tissues. The neglect of these low LET radon progeny radiations is rea-
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sonably prudent since their LETs and hence RBEs are so much lower than
the radon and progeny alpha particles as seen from the Miller et al. (1995)
data in Figure A3 of Part I (Leonard et al. 2009a). The mean free path in
tissue of the progeny gamma rays (Rockwell 1956) vary from about 5.6 cm
(for the 222Rn 0.19 MeV gamma ray) to about 22 cm (for the 214Bi 2.44
MeV gamma), thus the gamma rays are correctly assumed to escape inter-
action to the lung tissue when emitted within the lung tissue itself from the
deposited radon progeny. The case for the progeny betas is quite different
in our effort to account for single traversals through the lung cells. As seen
in the Figure 6, a progeny emitted beta ray is locally absorbed but travers-
es many cell diameters in its slowing down process. Only in a few cases
involving radon research has radon progeny beta ray dose from radon
progeny been evaluated, such as the extensive program of Cross (1988) in
vivo exposure of dogs to high levels of radon and the in vitro exposure of
human lymphocytes to radon progeny radiations (Pohl-Ruling 1988). A
special team of dosimetry specialists evaluated the beta dose in the expo-
sures (Jostes et al. 1991) for both the Cross (1988) and Pohl-Ruling (1988)
studies. For the Pohl-Ruling (1988) exposures they estimated that about
5% of the dose was radon progeny beta dose since radon gas was a princi-
ple exposure source as well as the progeny. This is because much of the
betas energy is expended outside the very thin in vitro samples. For the
beta rays emitted from the radon progeny deposited in the lung, we esti-
mate the beta dose to be about 20% of the radon dose in mGy. The beta
dose will vary linearly with radon concentration i.e. we let
Beta Dose (in mGy) = 0.20 ± 0.05 x Radon Dose (in mGy) (10)
As Figure 13A, we show the radon progeny beta annual dose equiva-
lent as a function of radon concentration. To consider the two lung radi-
ation sources that are shown to vary with radon concentration (the U ter-
restrial shown in Figure 12D) and the radon betas, as Figure 13B we show
the total variation of U terrestrial dose equivalent for the 30 day lung cells
mitotic cycle from the British Columbia and the CA/ID data. Shown are
the standard errors also.
4. ANALYSIS
4.1 Computation of the Lung Cells Specific Energy Hit Rate at UNSCEAR
(2000) World-wide Average Low LET Human Exposure Rates
We have mentioned that, in Appendix A, we have computed the dose
components for the UNSCEAR (2000) world-wide averages. In Table A1,
we provide the tabulation of the individual external and internal radia-
tions making up the total exposures. Given are the energies of the betas
and gamma rays, the percent of decays for each decay transition for K-40,
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the Uranium series, and the Thorium series.and the proton cosmic rays.
Also given are the individual LETs for each radiation. In Table A1, the
LETs for K-40 and the U and Th series are averaged based on their per-
centage of decays. From these the Specific Energy Depositions per Hit are
computed and finally the Hits to the three sensitive lung cells for a 30 day
mitotic cycle are given. In Table A2, we compute the mean Specific Energy
Depositions per radiation induced charged particle through the three sen-
sitive lung cell components, <z1>. We provide the tabulation of the total
charged particle traversals from all the components to examine the prob-
ability of single traversals to activate adaptive response protection. The
Tables are described in more detail in Appendix A. From these calcula-
tions, we estimate that 0.338, 1.306 and 0.477 specific energy hits per cell
cycle are received per basal, bronchial secretory and bronchiolar secreto-
ry cells, respectively, at the UNSCEAR (2000) world-wide average human
annual radiation exposure levels. With these Poisson distributed mean
Hits, 29%, 73% and 38% respectively of the three sensitive lung cells are
protected. By neglecting the progeny beta dose and the Uranium gamma
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FIGURE 13. Panel A – Estimation of the variation in lung beta dose from the radon progeny deposit-
ed in the lung as a function of radon concentration. Panel B – Estimation of the human lung dose
from the terrestrial Uranium gamma ray dose as a function of radon concentration. Shown is the esti-
mated based on the British Columbia (BC 2008) and for the CA/ID (EPA 2003) data. 
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dose that vary with radon concentration, at zero radon concentration,
0.150, 0.656 and 0.239 cells are hit, providing about 10%, 58% and 20%
adaptive response protection to humans not even exposed to radon.
4.2 Radon Variation - Combined Alpha Particle Bystander Effects and
Adaptive Response Protection for UNSCEAR (2000) World-wide Average
We have concluded, for our evaluation here of the specific energy hits
to the human lung cells, that an assumption of constant dose rates for the
human doses from medical, cosmic, internal, Thorium series and
Potassium-40, based on UNSCEAR (2000) world-wide averages is suffi-
cient for our analysis. We have however concluded that the dose rates for
the terrestrial Uranium series gamma rays and the beta ray dose rate from
the deposited radon progeny must be treated as variable in our analysis.
In Figure 13B, based on the terrestrial Uranium gamma ray dose varia-
tions with radon concentration from the British Columbia and the com-
bination CA and ID data in Figure 12, we have provided the estimated
variation in the doses from the terrestrial Uranium gamma ray dose in the
two cases. Both are normalized to the UNSCEAR (2000) world average of
0.122 at the indoor radon median radon level of 24.3 Bq m-3. We allow the
Uranium dose to vary with radon level. We have then used the same
method as in the Appendix A Tables A1 and A2 in Table A3 to compute
the Specific Energy Hits per 30 day cycle as a function of varying radon
concentration for the variation in beta dose with radon variation but for
the two separate Uranium gamma ray variation cases. Figures 14A, 14B
and 14C provide these data for the British Columbia for the three lung
cell species. Figures 15A, 15B and 15C provide the Specific Energy Hits
per 30 day cycle for the CA/ID case. We show, in Table A3, each compo-
nents contribution to the overall net Specific Energy Hits per Nucleus per
30 day cycle. Where the net Specific Energy Hits curve crosses unity, a
Poisson mean of one charged particle traversal has occurred per cell
nucleus. As Figures 16A and 16B we show the adaptive response protec-
tion factor in blue, the alpha particle Excess Relative Risk from the
Bystander Effect and Direct Damage without AR protection and the Net
Dose Response (in terms of Radon Lung Cancer Risk) considering the
alpha particle damage and also the adaptive response protection against
the damage from the Specific Energy Hits in Figures 14 and 15.
Having obtained an estimate of the variation in adaptive response radio-
protection as a function of increasing radon concentration at the residential
radon level up to 1000 Bq m-3, we now can estimate the reduction in Relative
Lung Cancer Risk starting with the dose response curves in Figure 16 of Part
I. Figure 16C of Part I extends the radon level to 2500 Bq m-3. In Figure 16
herein, for the UNSCEAR (2000) world-wide average doses, still comparing
the British Columbia and the CA/ID separate calculations, we show this nor-
malized representative alpha particle dose response, without AR reduction
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FIGURE 14. British Columbia U gamma data (BC 2008). The variation in lung Specific Energy Hits
for the separate dose components as a function of increasing radon concentration exposure. The cos-
mic, internal, medical external Thorium series and external K-40 are assumed constant at the
UNSCEAR (2000) worldwide averages. The radon progeny beta and Uranium gamma doses are var-
ied according to Figure 26 with increasing radon concentration. Panel A – Bronchial basal cells.
Panel B – Bronchial secretory cells. Panel C – Bronchiolar secretory cells. 
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FIGURE 15. Same as Figure 27 except for using the lower CA/ID U gamma ray data (EPA 2003) for
Specific Energy Hits with increasing radon concentration. 
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FIGURE 16. Based on the data in Figures 27 and 28 of Specific Energy Hits, the estimated human
lung dose response to alpha particle traversals (red curve) and to the adaptive response radio-pro-
tection (blue curve) and the combined effect on the human lung cancer risks with increasing radon
concentration. Panel A – The British Columbia data (BC 2008) from Figure 27. Panel B – the CA/ID
data (EPA 2003) from Figure 28. 
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(red curve), from Figure 16, Part I. The blue curve is the magnitude of the
AR protection based on the estimate in Figure 14 of Specific Energy Hits
(next to last column in Table A3) and the Table A3 calculation of AR pro-
tection (last column). The black curve is the net Relative Lung Cancer Risk
for the two calculations [BC (2008) and CA/ID]. We see that there is little
difference in the results in separately considering the estimated terrestrial
Uranium gamma ray dose based on the British Columbia data and the
California and Idaho (CA/ID) data. In the subsequent analysis, in
Figures 17 and 18, we will report the use of only the British Columbia data
believed to be more accurate since they were field measured.
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FIGURE 17. Considering the variation in human annual dose levels, based on UNSCEAR (2000)
data, from variation in geological and ecological conditions, the estimated maximums and mini-
mums are used to calculate the range of adaptive response radio-protection that may be expected
from the range of Specific Energy Hits based on these variations. Panel A – Maximum for British
Columbia Uranium dose data (BC 2008). Panel B – Maximum for CA/ID data (EPA 2003). Panel C
– Minimum for British Columbia data (BC 2008). Panel D – Minimum for CA/ID data (EPA 2003). 
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4.3 Examination of the Radon Relative Risks for the UNSCEAR (2000)
Maximum and Minimum Variations in Human Low LET Radiations to
Humans
Examining the EPA High-Radon Project data, the USGS Terrestrial
Gamma Ray data, the California Gamma Ray data from EPA (2003), the
residential data of Clouvas et al. (2001) and other data presented here in
Sections 3.2.c and 3.2.d, we have shown that there is a very large variation
in the human radiation exposures based on geographic location world-
wide. For this reason, from the Table 1 UNSCEAR (2000) typical range of
human radiation exposures by component, we have performed calcula-
tions for the low range values and the high range values of annual expo-
sures. In the low range case we used – cosmic rays 0.30 mSv; Terrestrial
gamma 0.30 mSv (U gamma 0.073 mSv; Th gamma 0.117 mSv; K-40
gamma 0.110 mSv); internal 0.20 mSv; and medical 0.02 mSv. Figure 17A
provides the Radon Relative Risks for the UNSCEAR (2000) low range
human exposure values. As Figure 17B, we show the maximum range cal-
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FIGURE 18. For the British Columbia data in Figure 16A, we show the effect of normalization to con-
trols at zero radon concentration with, in Panel A, the upper Adaptive Response protection (in blue)
and normalized case-control Net Dose Response (in black). Panel B is estimate of nomalized case-
control with a distribution of background levels. 
38
Dose-Response: An International Journal, Vol. 9 [2014], Iss. 4, Art. 8
https://scholarworks.umass.edu/dose_response/vol9/iss4/8
culations (High human low LET radiation exposures.). Here we used -
cosmic rays 1.00 mSv; Terrestrial gamma 0.60 mSv (U gamma 0.146 mv;
Th gamma 0.234 mSv; K-40 gamma 0.220 mSv); internal 0.80 mSv; and
medical 1.20 mSv. These large variations support a large variation in
human lung cancer risks for the case-control studies shown in Figures 2A
and 2B of Part I (Leonard et al. 2009a), which are further studied in Part
III (Leonard et al. 2009b). The normalized alpha particle representative
dose response given in Figure 16 of Part I further support a non-linear
BaD Model type dose response in the large variations in Figures 16 and
17. This will be shown to be true, in Part III (Leonard et al. 2009b), for
the case-control studies. There is a difference relative to the expected
dose response from case-control studies and what we have predicted in
Figures 16 and 17 for combined bystander and adaptive response effects.
Since case-control studies involve comparisons between lung cancer and
non-lung cancer cohorts in the same geological and ecological settings
they are normalized to unity at zero radon exposure and not worldwide
or national “spontaneous” lung cancer rates (without radon exposure).
We show this normalization of the Appendix A calculations to unity for
case-control studies in Figure 18.
5. SUMMARY
In Part I of this three part study, alpha particle and other high LET
broad-beam and micro-beam in vitro data (Miller et al. 1995, 1999, Zhou
et al. 2003, 2004, Nagasawa and Little 1999, 2002, Hei et al. 1997, Sawant
et al. 2001a, 2001b) were examined with the Brenner et al. (2001) micro-
dosimetry, bystander BaD Model. This model has been used by others
(Little and Wakeford 2001, Little 2004, Brenner and Sachs 2002, Brenner
et at 2001) with the a priori assumption that at least some radon induced
human lung cancers are caused by bystander damaged cells. It was found
that for alpha particles with LETs near that of radon progeny alpha par-
ticles, that a standard representative alpha particle dose response shape
with BaD Model parameters within ± 10% SD when scaled to microdose
alpha particle cell traversals. This standard representative shape was then
normalized to the BEIR VI (1999) Relative Risk at 400 Bq m-3 radon con-
centration to provide a best estimate of human lung cancer Relative Risk
dose response. This best estimate is non-linear with the lung cancer inci-
dence at low radon domestic levels from Bystander cellular damage and
at high underground miner radon levels from direct alpha traversals.
This Part II here, of the three part study, has examined the potential
influence of the adaptive response radio-protection on human lung can-
cer risks from radon. Radiation source of this protection is considered to
be the natural background and man-made radiation to which humans are
exposed on a day-to-day basis. The UNSCEAR (2000) world-wide estimate
of human radiation exposures, Table I, is used for the radiation source
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components. Fundamental to the examination process is the knowledge
that single low LET charged particle traversals activates the AR protective
mechanism, it persists for at least one mitotic cell cycle, is relatively inde-
pendent of the inducing low LET radiations and produces a reduction in
both radiation induced and natural spontaneous chromosome damage
by 50 to 80% (Leonard 2005, 2007a, 2007b, 2008a, 2008b, Leonard and
Leonard 2008).
It is shown from a number of radiation surveys that there is a very
wide range of natural background and man-made exposures from region-
to-region and even in localized areas within regions. The Appendix A,
Tables A1, A2 and A3 computes the Specific Energy Hits and adaptive
response protection factors to the three carcinogenically sensitive lung
cell species at the UNSCEAR (2000) world-wide average (40% AR reduc-
tion), with the estimated variation radon level and with the maximum
(80% AR reduction) and minimum (20% AR reduction) range of human
low LET exposures. Each Relative Risk curve (Figures 16, 17 and 18)
show non-linear Bystander Damage dose response for residential and
workplace human exposures and Direct Damage for underground miner
exposures.
APPENDIX A
EXAMINATION OF POTENTIAL ADAPTIVE RESPONSE SUPPRESSION OF
RADON ALPHA PARTICLE HUMAN LUNG CELLULAR BYSTANDER AND
DIRECT DAMAGE
A.1 Sources Adaptive Response Producing Low LET Radiations Received by
Humans
In Section 3.3.a.1 above, we note that Americans receive a population
averaged annual radiation dose equivalent of about 2.4 mSv of back-
ground radiation of which 39 % is low LET, consisting primarily of about
20% terrestrial gamma rays, 12% a cosmic ray component and 7% inter-
nal (ingestion) component, and 52 % from high LET Radon progeny
(BEIR VII 2006, UNSCEAR 2000). It is also noted that we receive an
annual average of about 0.5 mSv of man-made radiation, of which at least
98 % is low LET. Thus, the major components of our total population
averaged annual dose of 2.9 mSv is about 1.44 mSv low LET and about
1.25 mSv high LET Radon progeny alphas. We shall use two methods to
evaluate the possibility and probability of Adaptive Response radio-pro-
tection against the incidence of lung cancer. Adaptive Response has been
shown to be activated by Poisson accumulated; low LET radiation pro-
duced single charged particle traversals through individual cells. Because
the energy deposited to the lung cells per traversal varies with the LET of
the charged particles, to estimate the potential of the radiations to induce
adaptive response reduction in lung cancer risks from radon, we must
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TABLE A1. The Terrestrial Gamma Ray Spectra. Panel A – The Total spectrum including Uranium
series, Thorium series and 40K gammas. Panel B – the Uranium series gamma spectrum. Panel C –
The Thorium series gamma spectrum. Panel D – The Potassium-40 gamma ray spectrum. 
FIGURE A1.
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42
Dose-Response: An International Journal, Vol. 9 [2014], Iss. 4, Art. 8
https://scholarworks.umass.edu/dose_response/vol9/iss4/8
evaluate each source of radiation. We will first examine the low LET radi-
ations charged particle traversal frequency for the different human expo-
sure sources at the above cited average levels. For consistency we will use
the UNSCEAR (2000) world-wide average annual doses for each compo-
nent. Table 1 lists these as given in UNSCEAR (2000).
A.1.a Beta Ray Dose From the Radon Progeny
Along with the two radon progeny alpha emissions, there are 14 prog-
eny gamma rays, ranging in energies from 0.05 to 2.44 MeV, and 7 prog-
eny beta particles, ranging in maximum energies from 0.69 to 3.26 MeV.
Figure A2 provides the decay scheme for 226Ra, showing the 222Rn and the
progeny radiations. In Table A1, we list the gammas above 1% emission
and the 7 beta rays from the Radon progeny. In the radon in vitro expo-
sure environment for the Pohl-Ruling (1988) human lymphocyte expo-
sures shown in Figure 6D of the main text, these low LET progeny radia-
tions are estimated to deliver only about 5% of the Radon alpha lung
dose (Josters et al. 1991) if 218Po is deposited within the cell medium since
a significant fraction of the betas escape from the in vitro cultures with
most of their kinetic energies. For human exposure to radon and its air-
borne progeny, we need to evaluate the indoor equilibrium levels of the
progeny. The four decay products are 218Po (alpha emitter, 3.05 minute
half-life), 214Pb (beta emitter, 26.8 minute half-life), 218Bi (beta emitter,
19.7 minute half-life) and 214Po (alpha emitter, 164 second half-life). If
they were in secular equilibrium the ratio of betas-to-alphas would be 1 to
1. The ratios have been extensively studied (NRC 1991, BEIR VI 1999)
and as a rule they are not in equilibrium. The typical ratio for the decay
products are 5 (218Po)/ 3 (214Pb) / 2 (214Bi) / 2 (214Po). This gives a beta-
to-alpha ratio of 5 to 7. The equilibrium fraction chosen is thus about
0.42. By tabulating the energies of the beta decays and the alpha decays,
we compute that if all the kinetic energies are deposited in the lung tis-
sue then the betas deposition will be 24.6 % of the alpha deposition ener-
gy. We must consider the fact that the range of the 214Po betas (2.0 and
3.26 MeV) are about 0.98 and 1.63 cm respectively in tissue. These sig-
nificant ranges, in terms of cell diameters, compared to the in vitro expo-
sure samples for the Pohl-Ruling (1988) exposures is why the beta dose
was only 5% of the alpha dose. The extensive study of the physiology of
the lung with respect to alpha particle exposure is given in NRC (1991).
The adult lung has a total mass of from 300 to 400 grams. Its volume is
about 5.5 liters, so most of the lung consists of conducting airways and
blood circulatory system for exchange of carbon dioxide laden old air
with oxygen fresh new air. From a geometric viewpoint, the two lung sec-
tions, consisting of 150 to 200 grams of tissue and volume of 2.75 liters,
will mean that at least 75% of the beta rays energy will be deposited with-
in the lung tissue. Then our best estimate is that the beta dose to the lung
from the radon progeny is about 20 ± 5% of the alpha dose (in Gy) to the
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lung. These beta rays are thus important in our evaluation of low LET
Adaptive Response effects from the Radon progeny and we shall use a
lung beta dose of 20% of the Radon alpha dose in our calculations shown
in Tables A1 and A2.
A.1.b Terrestrial Radiations
The properties of terrestrial radiations are well known. They consist of
three basic components, Potasium-40, the Uranium natural radioactive
series and the Thorium natural radioactive series. There have been exten-
sive United States (US) national and worldwide surveys of these radiations.
As Figure A1A, we provide the gamma ray spectrum for background radi-
ation as determined with a high resolution Germanium solid-state radia-
tion detector and a multi-channel spectrometer system. Shown is the sin-
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gle 1.461 MeV gamma ray from 40K, the 5 214Bi gamma rays from the
Uranium series and the 3 gamma rays from the Thorium series. As Figures
A1B, A1C and A1D, we show the separate resolved spectra for 40K, the
Uranium series and the Thorium series gamma rays. Knowing the gamma
ray energies and the relative decay fractions, the effective LETs of each
radiation component is provided in Table A1. UNSCEAR (2000) estimates
the separate annual dose equivalent components to be 0.122 mSv/a, 0.195
mSv/a and 0.183 mSv/a for Uranium, Thorium and Potassium-40, respec-
tively, using the UNSCEAR (2000) world-wide annual average terrestrial
gamma ray dose equivalent is 0.50 mSv/a. These values are used in Table
A2 to compute the Specific Energy Hits per radon 30 day cell cycle.
A.1.c Cosmic “Rays”, Internal and Medical Radiation Exposures
We have put quotation marks around the word ray because the nor-
mal cosmic ray spectrum consists primarily of high energy protons (about
89%) and helium atoms (about 10%) - not rays. The kinetic energy of the
protons are about 200 MeV. Elmore et al. (2005) have measured the dose
response of 232 MeV proton exposure to HeLa x skin cells (see Figure 4D
herein) showing an AR protection. The LETs used in Table A1 for the
photons, beta rays and protons are estimated from Attix (1986), Hall
(2000) and Figure 1-1 of ICRP (2004).
UNSCEAR estimates that most of the internal dose for humans to be
about 0.180 mSv from ingestion of Potassium-40 in food products. The
remaining 0.120 mSv dose equivalent is primarily from the Uranium and
Thorium series isotopes. The annual medical exposure of 0.40 mSv/a is bro-
ken down into various world population with respect to health care capabil-
ities. The exposures are primarily from low energy diagnostic X-rays, mam-
mograms, CT scans and some internal medicine isotopic injects as tracers.
A.2 Computations in Tables A1 and A2 for Low LET Charged Particle
Traversals from UNSCEAR (2000) Annual Doses
We have explained the data in Table A1 in the previous section. The
Equation (7) of the main text was used to compute the mean Specific
Energy depositions per radiation induced charged particle traversal (hit)
in units of cGy per hit. In Table A2, we have computed the Specific Energy
depositions per hit (traversal) in Columns 4 and 5. This was based on the
LETs of the radiation and the lung cell total and nucleus diameters
(Columns 2 and 3) for the bronchial basal, bronchial secretory and bron-
chiolar secretory sensitive lung cells. In Table A2, the annual dose equiva-
lents used are given in Column 6. Columns 7 and 8 provide the total hits
per year and finally Columns 9 and 10 provide the total hits per 30 day
lung cell cycle for each cell species for each exposure category. At the bot-
tom in Columns (9) and (10), we provide the total low LET radation
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induced charged particle traversal to each of the lung cell species. Since
the bronchial secretory cells are the largest they receive the most hits.
A.3 Computation of the Variation in Adaptive Response Protection with
Variation in Radon Concentration.
As described in the main text, we have estimated the variation in lung
cell Specific Energy Hits and the adaptive response radio-protection. We
have assumed constant representative human exposure values for the cos-
mic, medical, terrestrial Potassium-40 and Thorium series and internal
dose. The radon progeny beta and the terrestrial Uranium dose is
assumed to vary with increasing radon concentration as shown in Figure
13. Table A3 provides a section of the spread sheet used for the tabulation
on hits and then the Poisson activation of the adaptive response shown in
Figures 14 and 15. In Table A3, the first column is the radon concentra-
tion, the subsequent columns are the constant values for the doses held
constant. The last two columns are the variation in the radon progeny beta
dose and terrestrial Uranium dose with radon. The far right column are
the adaptive response protections to produce Figures 14 and 15.
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APPENDIX B
DEFINITIONS OF PARAMETERS IN THE BYSTANDER EFFECT AND
ADAPTIVE RESPONSE MICRODOSE MODEL, EQUATIONS (1) AND (3) –
LEONARD (2008A)
Adaptive Response Parameters
Pspo = Zero priming absorbed dose, spontaneous damage level
RR - Relative Risk - The observed damage level normalized to the
spontaneous damage level at zero priming dose (Pspo).
Pprot-s∞ = The magnitude of the Adaptive Response radio-protection
when 100% of the cells are activated and the radio-protection for the
spontaneous damage is fully developed.
Pprot-pr∞ = The magnitude of the Adaptive Response radio-protection
when 100% of the cells are activated and the radio-protection for the
primer radiation damage is fully developed.
PAFs(M,N) = The Poisson Accumulation Function as a function of
mean number of cell charged particle traversals, M, for the minimum
number of Poisson distributed traversals to activate the Adaptive
Response radio-protection, N, for the spontaneous damage.
PAFpr(M,Q) = The Poisson Accumulation Function as a function of
mean number of cell charged particle traversals, M, for the minimum
number of Poisson distributed traversals to activate the Adaptive
Response radio-protection, Q, for the primer dose damage.
RP(t, to) = The Adaptive Response activation and fading function as a
function of time after administering the primer dose and time for the
threshold for fading of the AR, to. See Equation (5) of Leonard (2007b).
f(D) = The Adaptive Response retention function as the high dose
Direct Damage is induced. f(D) = 1.0 as D increases for full retention of the
AR radio-protection. f(D) = 0 if the AR is fully dissipated as D increases.
Bystander Effect Parameters, Equations (4), (5) and (6) – Brenner et al. (2001)
σ = The fraction of cells that are hypersensitive to oncogenic trans-
formation by the bystander signal. For protective Bystander Effects, σ will
be negative as a result of the receptor, hypersensitive cells activating pro-
tective mechanisms as illustrated in Leonard and Leonard (2008). For
deleterious Bystander Effects, σ will be positive as illustrated by Brenner
et al. (2001). k = The number of un-irradiated cells per unit dose (cGy-1)
that actually receive a bystander responsive signal.
q = The probability per unit dose (cGy-1) of a cell surviving a single
alpha particle traversal of its nucleus.
ξ = The fraction of traversed cells that become inactivated (non-
colony forming).
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The bystander effect is as a result of a small population of hypersen-
sitive bystander receptor cells such that the [ Exp ( - ξ q D) ] (Depletion≅
function in Equation (1) characterizes the depletion of these hypersensi-
tive cells by inactivation by Hits from the direct damage. The [ 1- Exp ( - k
D) ] (Hit probability≅ function provides the probability per unit dose that
at least one cell is directly Hit where as noted k is the number of un-Hit
neighbor cells receiving the bystander signal. The combined product [ 1-
Exp ( - k D) ] [ Exp ( - ξ q D) ] facilitates the dose and specific energy
Hits dependence of the total Bystander Damage component.
Direct Damage Parameters
α and β = Linear (cGy-1) and quadratic (cGy-2) Direct Damage coeffi-
cients from the conventional Linear-Quadratic dose response formulism
(Kellerer and Rossi 1972).
PAFD(M,U) = The Poisson Accumulation Function for low LET adap-
tive response effects as a function of mean number of cell charged parti-
cle traversals, M, for the minimum number (threshold) of Poisson dis-
tributed traversals to induce radiation damage (Direct Damage) from the
primer dose radiation, U.
N(M,V,SD) = The Normal Distribution accumulation function for the
transition threshold between low alpha dose Bystander Damage Region
and the high alpha dose Direct Damage Region. V is the mean number
of alpha particles to induce the transition and SD is the standard devia-
tion of the Normal Distribution (width at 1/2 maximum).
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